Day One to Attend the 37th Annual Healthcare Conference Hosted by Piper Sandler

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Nov 18 2025

0mins

Source: Globenewswire

Company Announcement: Day One Biopharmaceuticals will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 4:00 p.m. EST, with a live webcast available for viewing.
Focus on Pediatric Cancer: The company aims to address the lack of therapeutic development in pediatric cancer, inspired by the initial conversations between physicians and families regarding cancer diagnoses and treatment plans.
Collaborative Approach: Day One partners with clinical oncologists, families, and scientists to develop targeted cancer treatments, with a pipeline that includes tovorafenib (OJEMDA™) and DAY301.
Investor Relations: The company utilizes its Investor Relations website and social media platforms to communicate news, announcements, and financial performance to stakeholders.

Discover Tomorrow's Bullish Stocks Today

Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.